AT2101 (afegostat tartrate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT2101 (afegostat tartrate), covering 2018-08-15 to 2018-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy [Phase 2]